Limited clinical data supporting the long-term safety of nasal administration
Redox disequilibrium can cause melanocyte death by activating cytotoxic T cells and other death modalities such as apoptosis, necroptosis, and necrosis or oxeiptosis [6]
How BPC-157 Dosage Is Determined: The Clinical Approach Because BPC-157 has no FDA-approved dosage, every clinical protocol is built from preclinical data, provider experience, and individualized patient assessment
For the coated tablet form, the patient should take the tablet with plain water, either before or after meals, and must not crush or chew the tablet
From a 5 mg/mL vial, 10 units instead of 5 units means you took 0.5 mg instead of 0.25 mg
Safe use requires baseline labs, periodic monitoring of glucose and cortisol, and close provider communication